Siemens Medical Systems' nuclear medicine group of Hoffman Estates, IL, rolled into the Radiological Society of North America meeting last month with a new offering in its E.Cam line. The company introduced E.Cam Cardiac Imaging System for dedicated
Siemens Medical Systems' nuclear medicine group of Hoffman Estates, IL, rolled into the Radiological Society of North America meeting last month with a new offering in its E.Cam line. The company introduced E.Cam Cardiac Imaging System for dedicated cardiac SPECT applications and cardiac perfusion studies. The new camera is part of the group's ongoing effort to reach market niches by segmenting its gamma camera lineup.
The new E.Cam has detector heads that can be positioned in both 90 and 76 configurations for automatic body contouring, and its cardiology software package includes the Advanced Emory Cardiac Toolbox. Like other E.Cams, it employs a workstation based on Apple's Macintosh G3 computer.
The cardiac system adds a fifth camera to the company's other E.Cam offerings: a variable-angle system, a dual-head, 180 unit, a single-head camera, and a coincidence unit. Siemens expects the new E.Cam to list in the $280,000 to $340,000 range.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.